RETA logo

Reata Pharmaceuticals (RETA) Depreciation And Amortization

Annual D&A

$1.13 M
-$73.00 K-6.07%

December 31, 2022

Summary

Performance

1-Year Change

-6.07%

3-Year Change

+21.24%

5-Year Change

+158.58%

15-Year Change

+158.58%

RETA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.93 M
RETA annual depreciation & amortization is currently -61.39% below its historical high of $2.93 million

3-Year Low

$1.13 M
RETA annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
RETA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
RETA next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$280.25 M
RETA annual total expenses is $280.25 million

Annual Operating Expenses

$280.25 M
RETA annual total operating expenses is $280.25 million

Annual Cost Of Goods Sold

-
RETA annual cost of goods sold value is unknown

Annual Interest Expense

$41.77 M
RETA annual interest expense is $41.77 million

Quarterly D&A

$293.00 K
+$5000.00+1.74%

June 30, 2023

Summary

Performance

3-Month Change

+1.74%

1-Year Change

+7.33%

3-Year Change

+3.17%

5-Year Change

+179.05%

RETA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$533.00 K
RETA quarterly depreciation & amortization is currently -45.03% below its historical high of $533.00 thousand

3-Year Low

$272.00 K
RETA quarterly depreciation & amortization is currently +7.72% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
RETA previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
RETA next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$103.95 M
RETA quarterly total expenses is $103.95 million

Quarterly Operating Expenses

$103.10 M
RETA quarterly total operating expenses is $103.10 million

Quarterly Cost Of Goods Sold

$846.00 K
RETA quarterly cost of goods sold is $846.00 thousand

Quarterly Interest Expense

$7.97 M
RETA quarterly interest expense is $7.97 million

TTM D&A

$1.13 M
+$20.00 K+1.80%

June 30, 2023

Summary

Performance

3-Month Change

+1.8%

1-Year Change

-7.6%

3-Year Change

+3.39%

5-Year Change

+21.24%

RETA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.82 M
RETA TTM depreciation & amortization is currently -37.88% below its historical high of $1.82 million

3-Year Low

$1.11 M
RETA TTM depreciation & amortization is currently +1.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
RETA previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
RETA next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$280.25 M
RETA annual total expenses is $280.25 million

Annual Operating Expenses

$280.25 M
RETA annual total operating expenses is $280.25 million

TTM Cost Of Goods Sold

$846.00 K
RETA TTM cost of goods sold is $846.00 thousand

TTM Interest Expense

$40.61 M
RETA TTM interest expense is $40.61 million

RETA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.1%+7.3%-7.6%
3 y3 years+21.2%+3.2%+3.4%
5 y5 years+158.6%+179.1%+21.2%

RETA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.1%at low-9.3%-7.2%-8.6%-1.8%
5 y5-year-6.1%-17.5%-9.3%-7.2%-8.6%-17.5%
alltimeall time-61.4%-61.9%-45.0%-66.9%-37.9%-64.2%

Reata Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2023
-
$293.00 K(+1.7%)
$1.13 M(+1.8%)
Mar 2023
-
$288.00 K(+4.0%)
$1.11 M(-1.8%)
Dec 2022
$1.13 M(-6.1%)
$277.00 K(+1.8%)
$1.13 M(-3.9%)
Sep 2022
-
$272.00 K(-0.4%)
$1.18 M(-3.8%)
Jun 2022
-
$273.00 K(-11.4%)
$1.22 M(-1.1%)
Mar 2022
-
$308.00 K(-4.6%)
$1.24 M(+2.8%)
Dec 2021
$1.20 M(+5.9%)
$323.00 K(+1.3%)
$1.20 M(+3.3%)
Sep 2021
-
$319.00 K(+11.1%)
$1.17 M(+2.6%)
Jun 2021
-
$287.00 K(+4.7%)
$1.14 M(+0.3%)
Mar 2021
-
$274.00 K(-3.9%)
$1.13 M(-0.4%)
Dec 2020
$1.14 M(+21.9%)
$285.00 K(-1.4%)
$1.14 M(+1.1%)
Sep 2020
-
$289.00 K(+1.8%)
$1.12 M(+2.8%)
Jun 2020
-
$284.00 K(+2.2%)
$1.09 M(+5.1%)
Mar 2020
-
$278.00 K(+1.8%)
$1.04 M(+11.6%)
Dec 2019
$932.00 K(+116.2%)
$273.00 K(+5.8%)
$932.00 K(+19.6%)
Sep 2019
-
$258.00 K(+11.7%)
$779.00 K(+24.4%)
Jun 2019
-
$231.00 K(+35.9%)
$626.00 K(+25.2%)
Mar 2019
-
$170.00 K(+41.7%)
$500.00 K(+16.0%)
DateAnnualQuarterlyTTM
Dec 2018
$431.00 K(-1.4%)
$120.00 K(+14.3%)
$431.00 K(+4.6%)
Sep 2018
-
$105.00 K(0.0%)
$412.00 K(+2.0%)
Jun 2018
-
$105.00 K(+4.0%)
$404.00 K(-1.0%)
Mar 2018
-
$101.00 K(0.0%)
$408.00 K(-6.6%)
Dec 2017
$437.00 K(-35.9%)
$101.00 K(+4.1%)
$437.00 K(-9.1%)
Sep 2017
-
$97.00 K(-11.0%)
$481.00 K(-13.2%)
Jun 2017
-
$109.00 K(-16.2%)
$554.00 K(-11.2%)
Mar 2017
-
$130.00 K(-10.3%)
$624.00 K(-8.5%)
Dec 2016
$682.00 K(-62.5%)
$145.00 K(-14.7%)
$682.00 K(-15.6%)
Sep 2016
-
$170.00 K(-5.0%)
$808.00 K(-28.1%)
Jun 2016
-
$179.00 K(-4.8%)
$1.12 M(-23.7%)
Mar 2016
-
$188.00 K(-30.6%)
$1.47 M(-19.0%)
Dec 2015
$1.82 M(-27.6%)
$271.00 K(-44.2%)
$1.82 M(+17.5%)
Sep 2015
-
$486.00 K(-8.1%)
$1.55 M(+45.8%)
Jun 2015
-
$529.00 K(-0.8%)
$1.06 M(+99.2%)
Mar 2015
-
$533.00 K
$533.00 K
Dec 2014
$2.51 M(-14.2%)
-
-
Dec 2013
$2.93 M
-
-

FAQ

  • What is Reata Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals annual D&A year-on-year change?
  • What is Reata Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals quarterly D&A year-on-year change?
  • What is Reata Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals TTM D&A year-on-year change?

What is Reata Pharmaceuticals annual depreciation & amortization?

The current annual D&A of RETA is $1.13 M

What is the all time high annual D&A for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high annual depreciation & amortization is $2.93 M

What is Reata Pharmaceuticals annual D&A year-on-year change?

Over the past year, RETA annual depreciation & amortization has changed by -$73.00 K (-6.07%)

What is Reata Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of RETA is $293.00 K

What is the all time high quarterly D&A for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high quarterly depreciation & amortization is $533.00 K

What is Reata Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, RETA quarterly depreciation & amortization has changed by +$20.00 K (+7.33%)

What is Reata Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of RETA is $1.13 M

What is the all time high TTM D&A for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high TTM depreciation & amortization is $1.82 M

What is Reata Pharmaceuticals TTM D&A year-on-year change?

Over the past year, RETA TTM depreciation & amortization has changed by -$93.00 K (-7.60%)